<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0005039'>Hypoxia</z:mp>-inducible factor (HIF), a key modulator of the transcriptional response to <z:mp ids='MP_0005039'>hypoxia</z:mp>, is increased in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the role of HIF in colon <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> in vivo remains unclear </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we found that intestinal epithelium-specific disruption of the von Hippel-Lindau <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor protein (VHL) resulted in constitutive HIF signaling, and increased HIF expression augmented colon <z:mp ids='MP_0002006'>tumorigenesis</z:mp> in the Apc(min/+) <z:e sem="disease" ids="C0021841" disease_type="Neoplastic Process" abbrv="">intestinal tumor</z:e> model </plain></SENT>
<SENT sid="3" pm="."><plain>Intestine-specific disruption of Vhl increased <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumor</z:e> multiplicity and progression from <z:mpath ids='MPATH_270'>adenomas</z:mpath> to <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>These effects were ameliorated in mice with double disruption of Vhl and HIF-2α </plain></SENT>
<SENT sid="5" pm="."><plain>Activation of HIF signaling resulted in increased cell survival in <z:mpath ids='MPATH_458'>normal</z:mpath> colon tissue; however, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mpath ids='MPATH_3'>apoptosis</z:mpath> was not affected </plain></SENT>
<SENT sid="6" pm="."><plain>Interestingly, a robust activation of cyclin D1 was observed in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> of Apc(min/+) mice in which HIF-2�� was activated in the intestine </plain></SENT>
<SENT sid="7" pm="."><plain>Consistent with this result, bromodeoxyuridine incorporation indicated that cellular proliferation was increased in <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumors</z:e> following HIF activation </plain></SENT>
<SENT sid="8" pm="."><plain>Further analysis showed that dysregulation of the intestinal iron absorption transporter divalent metal transporter-1 (<z:chebi fb="12" ids="28969">DMT</z:chebi>-1) was a critical event in HIF-2α-mediated colon <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>These data provide a mechanistic basis for the widely reported link between iron accumulation and <z:hpo ids='HP_0003003'>colon cancer</z:hpo> risk </plain></SENT>
<SENT sid="10" pm="."><plain>Together, our findings show that a <z:hpo ids='HP_0011010'>chronic</z:hpo> increase in HIF-2α in the colon initiates protumorigenic signaling, which may have important implications in developing preventive and therapeutic strategies for <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
</text></document>